EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment

Yusuke Taniyama iD, Keiichi Jingu iD, Chiaki Sato iD, Hiroshi Okamoto, Yohei Ozawa iD, Hirotaka Ishida, Naoto Ujiie iD, Michiaki Unno, Takashi Kamei iD

Cancers · 22.05.2026 · 18 (11) · 1681

DOI: 10.3390/cancers18111681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.05.2026. Verfasst von Yusuke Taniyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy in which radiotherapy plays a uniquely central role compared with other gastrointestinal cancers. Definitive chemoradiotherapy (dCRT) is widely used as a curative treatment; however, a substantial proportion of patients develop residual or recurrent disease, creating a complex clinical scenario that requires tailored salvage strategies. Salvage esophagectomy offers the potential for long-term survival but remains technically demanding and is associated with significant morbidity because of radiation-induced tissue damage. Less invasive local therapies, such as endoscopic submucosal dissection and photodynamic therapy, may provide effective treatment in selected patients, although their indications are limited by tumor characteristics and post-radiation fibrosis. In addition, immune checkpoint inhibitors have demonstrated promising efficacy in advanced ESCC and may represent a potential therapeutic option in the salvage setting. For patients who are not candidates for curative treatment, palliative esophageal stenting remains an important option for symptom relief, although prior radiotherapy may increase the risk of treatment-related complications. Given the diversity of available treatment modalities and their associated risks, a multidisciplinary and individualized treatment approach is essential. Further prospective studies are warranted to optimize treatment algorithms and improve outcomes in patients with ESCC after dCRT.

Schlagwörter

Stichwörter der Autor:innen

definitive chemoradiotherapyesophageal squamous cell carcinomasalvage surgery

Autor:innen und Institutionen

  • Department of Surgery, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.
  • Department of Radiation Oncology, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-chou, Aoba-ku, Sendai 980-8574, Miyagi, Japan.

ORCID-Profile: Yusuke Taniyama, Keiichi Jingu, Chiaki Sato, Yohei Ozawa, Naoto Ujiie, Takashi Kamei

Zitieren

APA

Taniyama, Y., Jingu, K., Sato, C., Okamoto, H., Ozawa, Y., Ishida, H., Ujiie, N., Unno, M., & Kamei, T. (2026). Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment. Cancers, 18(11), 1681. https://doi.org/10.3390/cancers18111681

Vancouver

Taniyama Y, Jingu K, Sato C, Okamoto H, Ozawa Y, Ishida H, et al. Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment. Cancers. 2026;18(11):1681. doi:10.3390/cancers18111681

BibTeX
@article{Taniyama2026,
  author = {Taniyama, Yusuke and Jingu, Keiichi and Sato, Chiaki and Okamoto, Hiroshi and Ozawa, Yohei and Ishida, Hirotaka and Ujiie, Naoto and Unno, Michiaki and Kamei, Takashi},
  title = {Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1681},
  doi = {10.3390/cancers18111681}
}
Kostenlos starten →